T. Rowe Price Investment Management’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,796,906
| Closed | -$21.7M | – | 630 |
|
|
2023
Q3 | $21.7M | Sell |
1,796,906
-106,300
| -6% | -$1.28M | 0.02% | 469 |
|
|
2023
Q2 | $20.1M | Sell |
1,903,206
-9,145
| -0.5% | -$96.8K | 0.01% | 474 |
|
|
2023
Q1 | $18.8M | Sell |
1,912,351
-5,675
| -0.3% | -$55.8K | 0.01% | 479 |
|
|
2022
Q4 | $28.2M | Buy |
1,918,026
+155,283
| +9% | +$2.28M | 0.02% | 420 |
|
|
2022
Q3 | $21.4M | Buy |
+1,762,743
| New | +$21.4M | 0.02% | 444 |
|